Calyxt, Inc.’s Lock-Up Period Will End on January 16th (NASDAQ:CLXT)
Calyxt’s (NASDAQ:CLXT) lock-up period is set to expire on Tuesday, January 16th. Calyxt had issued 7,000,000 shares in its public offering on July 20th. The total size of the offering was $56,000,000 based on an initial share price of $8.00. After the end of the company’s lock-up period, company insiders and major shareholders will be able to sell their shares of the company.
Several brokerages have weighed in on CLXT. Citigroup lowered shares of Calyxt from a “buy” rating to a “neutral” rating in a research note on Wednesday, September 27th. Zacks Investment Research raised shares of Calyxt from a “sell” rating to a “hold” rating in a research note on Tuesday, November 28th. Ladenburg Thalmann Financial Services began coverage on shares of Calyxt in a research note on Wednesday, December 20th. They set a “buy” rating and a $34.25 target price for the company. Wells Fargo & Co increased their target price on shares of Calyxt from $17.00 to $30.00 and gave the stock an “outperform” rating in a research note on Friday, September 29th. Finally, Jefferies Group increased their target price on shares of Calyxt to $27.00 and gave the stock a “buy” rating in a research note on Wednesday, November 1st. Two research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average target price of $29.05.
Calyxt (CLXT) opened at $23.39 on Friday. The company has a debt-to-equity ratio of 0.13, a quick ratio of 12.41 and a current ratio of 12.41. The firm has a market cap of $639.43 and a PE ratio of -25.70. Calyxt has a 12 month low of $9.26 and a 12 month high of $31.89.
Calyxt, Inc is a food and agriculture company. The Company is focused on delivering healthier specialty food ingredients, such as healthier oils and high fiber wheat, for consumers and agriculturally advantageous crop traits, such as herbicide tolerance to farmers. The Company also combines gene-editing technology and technical that enables to edit a plant genome to elicit the desired traits and characteristics.
Receive News & Ratings for Calyxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calyxt and related companies with MarketBeat.com's FREE daily email newsletter.